The Western medical treatment measures for choriocarcinoma are as follows:
First, Drug selection
In general early cases, a single drug can be used, with 5-Fu as the first choice. If the condition is urgent or has reached the late stage, then the combination of two or more drugs is needed. The commonly used is 5-fluorouracil (5-Fu) plus Regenerative toxin (ksm). 5-Fu and ksm have the best efficacy and few side effects, and are effective for metastasis to the lungs, gastrointestinal tract, urinary tract, and reproductive tract. It can be used for intravenous administration, arterial perfusion, intracavitary or intratumoral injection, and can also be taken orally.
Second, Common protocols
1. Monotherapy: The dosage used is larger than that of multiple drug use, such as 5-Fu 28-30mg/kg/day.
2. Combination therapy: The dosage is slightly smaller than that of monotherapy, and the number of days in the course is also shorter, such as 5-Fu 26mg/kg/day, Regenerative toxin 6ug/kg/day.
3. Drug dosage: To achieve satisfactory results, the dosage of various drugs must reach the maximum tolerance of the patient, especially for the first and second courses, which is more important. Appropriate drug selection and sufficient dosage can make most cases show rapid improvement. Specific dosage and usage are shown in the following table;
Drug name.
|
Route of administration.
|
Drug dosage.
|
Number of days in a course.
|
Interval between courses.
|
Indications for use.
|
Annotation.
|
6. Mercaptopurine (6-mp).
|
Oral.
|
6. ~6.5mg/kg/day, taken at 8 pm and 8 am.
|
10. Day.
|
3. ~4 weeks.
|
For general conditions.
|
Second-line medication.
|
5-. Fluorouracil (5-Fu).
|
Intravenous infusion.
|
28. ~30mg/kg/day.
|
10. Day.
|
2. Week.
|
Generally effective for patients with general condition and especially for vaginal pelvic metastasis.
|
Dissolved in 5% glucose 500ml, 2-8 hours slow infusion.
|
Infusion.
|
25. ~30mg/kg/day.
|
10. Day.
|
2. Week.
|
Brain, liver metastasis .
|
Week 6-mp.
|
Local injection.
|
150. ~50mg/time.
|
Times per 2-3 days.
|
Determined according to the condition.
|
Vaginal cervix metastatic pelvic mass.
|
.
|
Regenerative toxin (ksm).
|
Intravenous infusion.
|
8. ~10ug/kg/day.
|
10. Day.
|
2. Week.
|
For general conditions, it is suitable for lung metastases.
|
Added to 5% glucose 500ml and infused for 4 hours.
|
Lomustine (AT1438).
|
Intravenous infusion.
|
400. ~600mg/day.
|
10. Day.
|
2. ~3 weeks.
|
Used for patients with drug resistance mentioned above.
|
.
|
Methotrexate (MTX).
|
Intravenous infusion.
|
10. ~15mg/day.
|
5. ~7 days.
|
3. ~4 weeks.
|
For general conditions.
|
5. %Glucose 500ml点滴4 hours.
|
Intravenous injection.
|
10. ~15mg/day.
|
2. ~3 days/time, 3-4 times as a course.
|
According to the condition.
|
Suitable for brain metastases .
|
Dissolved in 4-6ml of distilled water.
|
Dacarbazine (AT1258).
|
Intravenous injection.
|
30mg/. Day.
|
10. Day.
|
3. Week.
|
For general cases.
|
20ml. Diluted in saline.
|
5Fu+ksm.
|
Intravenous infusion.
|
26mg/kg/. Day 6ug/kg/day.
|
8. Day.
|
3. Week.
|
All kinds of metastases.
|
Add two bottles and infuse one drug after the other.
|
4, Administration speed: there are certain requirements for the administration speed of various drugs. For example, for 5-Fu, it must be infused within 2 to 8 hours after being added to 500ml of 5% glucose solution; if infused too quickly, the toxicity is greater, and if infused too slowly, it may affect the efficacy.
5, Duration of the course: if the course is too long, the toxicity is greater, and if the course is too short, the efficacy is poor. Therefore, a course of treatment is generally recommended to be 8 to 10 days.
6, Administration route: the same drug, different administration routes have different effects. Therefore, it is best for patients with lung metastases to use intravenous administration, for patients with gastrointestinal metastases to use oral medication, and for patients with liver metastases to use portal vein administration, which has a good therapeutic effect.
7, Interval between courses: mainly based on the needs of the disease and the disappearance of drug toxicity. If the toxicity is mild, the blood count recovers quickly after stopping medication, and the interval can be shorter; if the toxicity is severe, the blood count recovers slowly, and the interval should be longer. The toxicity of 5-Fu or KSM is mild, about two weeks, while the toxicity of 6-mP and MTX is severe, about four weeks.
8, Observation of efficacy: after medication, the efficacy is generally not immediately observed. A significant decrease in the HCG content in blood and urine may appear after about 2 weeks after completing one course of treatment. The absorption of lung metastatic shadows also needs to be significantly observed about 3 weeks after stopping medication. Therefore, auxiliary examinations for observing efficacy should not be carried out too early, otherwise, it is easy to cause misjudgment, thinking that the treatment is ineffective.
9, Criteria for stopping medication: to achieve radical cure and reduce recurrence, the treatment must reach the standard of complete recovery.
The criteria for recovery include: clinical symptoms are absent; the lung metastatic lesions have completely disappeared; after the HCG level is continuously normal, 1 to 2 courses of consolidation therapy should be given before stopping medication and observation. Sometimes, in order to prevent recurrence in patients with severe symptoms, several courses of consolidation therapy can be used.
Three, surgical treatment
After the effectiveness of chemotherapy has been proven, surgical treatment is no longer as important as before, but in some cases, such as large lesions, it is estimated that chemotherapy cannot completely conquer the disease, or the HCG level decreases slowly during the treatment process, or uterine perforation with bleeding of intraperitoneal metastases, surgery is still an important method for treating choriocarcinoma to save the patient's life. Generally, a wide hysterectomy and bilateral omentectomy, parauterine venous plexus, and ovarian venous plexus resection are performed.
Four, Radiotherapy
Choriocarcinoma and malignant hydatidiform mole are sensitive to radiotherapy. If there are solitary lesions in the lungs, pelvis, abdomen, etc., where surgery is difficult or the regression after multiple courses of chemotherapy is not obvious, radiotherapy can be considered, using cobalt-60 or deep X-ray radiation, whole brain radiation can be performed for brain metastasis, and local treatment with radium can also be used for inoperable vaginal metastatic nodules. The appropriate dose of choriocarcinoma is 3000-4000cGy/3-4 weeks, and that of malignant hydatidiform mole is 2000-3000cGy/2-3 weeks.
Five, Treatment of Metastatic Lesions
1. Treatment for Vulvar and Vaginal Bleeding: If the metastatic tumor has not broken down, in addition to 5-Fu intravenous drip, 5Fu 250-500mg can be injected into the metastatic tumor. Inject once every 2-3 days until the metastatic tumor is significantly reduced. If the metastatic tumor has broken down and bled, a gauze pad can be used to apply pressure to stop the bleeding, or the gauze pad can be coated with sterile hemostatic drugs, such as Yunnan Baiyao, which is also effective. If the above methods still cannot stop the bleeding, surgery or suture can be considered.
2. Treatment for Intraperitoneal Hemorrhage: In case of acute and obvious intraperitoneal hemorrhage, immediate laparotomy should be performed to remove the uterus. Postoperative systemic chemotherapy should be continued.
3. Treatment for Brain Metastasis: Systemic chemotherapy. The first choice of drug is the commonly used combination chemotherapy of 5-Fu and ksm; symptomatic treatment, to make chemotherapy effective, to reduce intracranial pressure using mannitol or sorbitol 250ml, once every 4-6 hours, dripping for half an hour; sedation and control of convulsions can be achieved with diazepam, barbital, or Durotropine, etc.; prevent complications such as coma, convulsions, falls, bites, aspiration pneumonia, and good nursing care should be done. At the same time, timely correction of electrolyte imbalance and acid-base balance disorders should be carried out.
4. Treatment for Hemoptysis: It is difficult to treat in case of massive hemoptysis, and there is currently no very ideal treatment method. 20u of pituitary posterior lobe hormone can be added to 500ml of 5% glucose solution for intravenous drip; hemostatic drugs such as止血芳酸 and carboxybenzamide can be used; surgery, if the bleeding site can be determined, and conditions and time permit, consider emergency lobectomy. At the same time, attention should be paid to antishock and correction of anemia. Anti-infection and prevention of asphyxia caused by hemoptysis should be carried out.